Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ozge Ceyhan-Birsoy

Showing results (1-10 of 50) with videos related to

Pageof 5
Sort By:
Clinics in Laboratory Medicine|September 23, 2022
Germline Testing for the Evaluation of Hereditary Cancer PredispositionOzge Ceyhan-Birsoy
Trends in Cancer|January 19, 2020
Evolving Significance of Tumor-Normal Sequencing in Cancer CareDiana Mandelker, Ozge Ceyhan-Birsoy
JCO Precision Oncology|May 29, 2024
Tumor-Only Sequencing: A Story Only Half ToldOzge Ceyhan-Birsoy, Zsofia K Stadler
Journal of Clinical Neuromuscular Disease|February 22, 2017
A Novel Missense Variant in the AGRN Gene; Congenital Myasthenic Syndrome Presenting With Head DropMert Karakaya, Ozge Ceyhan-Birsoy, Alan H Beggs, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|May 26, 2026
Gynecologic Tumors and Precursor Lesions, Including p53-Aberrant Atypical Hyperplasia-like Endometrial Lesions, in Li-Fraumeni SyndromeYurika Nishikawa, Ozge Ceyhan-Birsoy, Pier Selenica, et al.
Human Mutation|April 27, 2018
NGS testing for cardiomyopathy: Utility of adding RASopathy-associated genesOzge Ceyhan-Birsoy, Maya M Miatkowski, Elizabeth Hynes, et al.
Journal of Neuromuscular Diseases|March 31, 2015
Whole Exome Sequencing Reveals <i>DYSF</i>, <i>FKTN</i>, and <i>ISPD</i> Mutations in Congenital Muscular Dystrophy Without Brain or Eye InvolvementOzge Ceyhan-Birsoy, Beril Talim, Lindsay C Swanson, et al.
Breast Cancer Research and Treatment|September 27, 2018
A synonymous germline variant PALB2 c.18G>T (p.Gly6=) disrupts normal splicing in a family with pancreatic and breast cancersCiyu Yang, Ozge Ceyhan-Birsoy, Diana Mandelker, et al.
Molecular Genetics & Genomic Medicine|May 29, 2020
Fumarate hydratase c.914T > C (p.Phe305Ser) is a pathogenic variant associated with hereditary leiomyomatosis and renal cell cancer syndromeKelsey E Breen, Maria I Carlo, Yelena Kemel, et al.
NPJ Precision Oncology|June 8, 2026
Independent somatic TP53 mutations in blood and tumor mimicking Li-Fraumeni syndrome in a 94-year-old manChuan Gao, Vikas Rai, Donna Wong, et al.
Pageof 5

Showing results (1-10 of 50) with videos related to

Sort By:
Pageof 5
Clinics in Laboratory Medicine|September 23, 2022
Germline Testing for the Evaluation of Hereditary Cancer PredispositionOzge Ceyhan-Birsoy
Trends in Cancer|January 19, 2020
Evolving Significance of Tumor-Normal Sequencing in Cancer CareDiana Mandelker, Ozge Ceyhan-Birsoy
JCO Precision Oncology|May 29, 2024
Tumor-Only Sequencing: A Story Only Half ToldOzge Ceyhan-Birsoy, Zsofia K Stadler
Journal of Clinical Neuromuscular Disease|February 22, 2017
A Novel Missense Variant in the AGRN Gene; Congenital Myasthenic Syndrome Presenting With Head DropMert Karakaya, Ozge Ceyhan-Birsoy, Alan H Beggs, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|May 26, 2026
Gynecologic Tumors and Precursor Lesions, Including p53-Aberrant Atypical Hyperplasia-like Endometrial Lesions, in Li-Fraumeni SyndromeYurika Nishikawa, Ozge Ceyhan-Birsoy, Pier Selenica, et al.
Human Mutation|April 27, 2018
NGS testing for cardiomyopathy: Utility of adding RASopathy-associated genesOzge Ceyhan-Birsoy, Maya M Miatkowski, Elizabeth Hynes, et al.
Journal of Neuromuscular Diseases|March 31, 2015
Whole Exome Sequencing Reveals <i>DYSF</i>, <i>FKTN</i>, and <i>ISPD</i> Mutations in Congenital Muscular Dystrophy Without Brain or Eye InvolvementOzge Ceyhan-Birsoy, Beril Talim, Lindsay C Swanson, et al.
Breast Cancer Research and Treatment|September 27, 2018
A synonymous germline variant PALB2 c.18G>T (p.Gly6=) disrupts normal splicing in a family with pancreatic and breast cancersCiyu Yang, Ozge Ceyhan-Birsoy, Diana Mandelker, et al.
Molecular Genetics & Genomic Medicine|May 29, 2020
Fumarate hydratase c.914T > C (p.Phe305Ser) is a pathogenic variant associated with hereditary leiomyomatosis and renal cell cancer syndromeKelsey E Breen, Maria I Carlo, Yelena Kemel, et al.
NPJ Precision Oncology|June 8, 2026
Independent somatic TP53 mutations in blood and tumor mimicking Li-Fraumeni syndrome in a 94-year-old manChuan Gao, Vikas Rai, Donna Wong, et al.
Pageof 5